Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

Coronavirus envelope protein: current knowledge
Dewald Schoeman, Burtram C. Fielding
Virology Journal (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 2081
A review on drug repurposing applicable to COVID-19
Serena Dotolo, Anna Marabotti, Angelo Facchiano, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 2, pp. 726-741
Open Access | Times Cited: 160
Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor
Sarah O’Keefe, Peristera Roboti, Kwabena B. Duah, et al.
Journal of Cell Science (2021) Vol. 134, Iss. 4
Open Access | Times Cited: 33
Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase
Matthew R. Freidel, Roger S. Armen
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246181-e0246181
Open Access | Times Cited: 29
Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study
Dharmendra Kashyap, Shweta Jakhmola, Deeksha Tiwari, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 21, pp. 10629-10650
Closed Access | Times Cited: 21
Current and Future Direct-Acting Antivirals Against COVID-19
Shiu‐Wan Chan
Frontiers in Microbiology (2020) Vol. 11
Open Access | Times Cited: 21
Identifying and repurposing antiviral drugs against severe acute respiratory syndrome coronavirus 2 with in silico and in vitro approaches
Koichi Watashi
Biochemical and Biophysical Research Communications (2020) Vol. 538, pp. 137-144
Open Access | Times Cited: 16
Unraveling viral drug targets: a deep learning-based approach for the identification of potential binding sites
Petr Popov, R.Е. Kalinin, Pavel Buslaev, et al.
Briefings in Bioinformatics (2023) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Molecular docking studies of natural immunomodulators indicate their interactions with the CD40L of CD40/CD40L pathway and CSF1R kinase domain of microglia
Shashank Kumar Maurya, Rajnikant Mishra
Journal of Molecular Modeling (2022) Vol. 28, Iss. 4
Closed Access | Times Cited: 4
Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target
Jaewoo Hong, Hyunjhung Jhun, Yeo-Ok Choi, et al.
Immune Network (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Time dependent dihedral angle oscillations of the spike protein of SARS-CoV-2 reveal favored frequencies of dihedral angle rotations
Oscar Bastidas, Zoran Sevarac
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Anti-diabetic drug pioglitazone reduces Islet amyloid aggregation overload in the Drosophila neuronal cells
Khushboo Sharma, Pooja Rai, Shashank Kumar Maurya, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
In silico investigation of binding propensity of hematoxylin derivative and damnacanthal for their potential inhibitory effect on HIV-1 Vpr from different subtypes
Joyeeta Datta, Satyabrata Majumder, Dwaipayan Chaudhuri, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 14977-14988
Closed Access | Times Cited: 1
In silico identification of five binding sites on the SARS-CoV-2 spike protein and selection of seven ligands for such sites
Denilson F. Oliveira
Journal of Biomolecular Structure and Dynamics (2023), pp. 1-19
Closed Access | Times Cited: 1
Simulación de la proteína SPIKE COVID19 en laboratorios de informática educativa
Erwin Leonidas Blanco San Martín, Fabiola Sáez-Delgado, Lorena Blanco
CienciAmérica (2020) Vol. 9, Iss. 2, pp. 369-381
Open Access | Times Cited: 1
Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor
Sarah O’Keefe, Peristera Roboti, Kwabena B. Duah, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1
Rationalizing Viral Drug Target Identification Using Computational Approaches : The SARS-CoV-2 Spike Glycoprotein S Case Study
Petr Popov, Pavel Buslaev, Igor Kozlovskii, et al.
(2020)
Closed Access
Rationalizing Viral Drug Target Identification Using Computational Approaches : The SARS-CoV-2 Spike Glycoprotein S Case Study
Petr Popov, Pavel Buslaev, Igor Kozlovskii, et al.
(2020)
Closed Access
Page 1

Scroll to top